Payment overview · 2025
General Payments
$125.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Tiffany Pluto, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · SCOTTDALE, PA · NPI 1073515441
Verified facts
What the public records show
CMS Open Payments records show Tiffany Pluto, D.O. received $125.00 in general payments during 2025 across 1 reported records.
INTUITIVE SURGICAL, INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $125.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $125.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 781 | 150 |
| Amlodipine Besylate | Amlodipine Besylate | 624 | 152 |
| Atorvastatin Calcium | Atorvastatin Calcium | 485 | 116 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 381 | 106 |
| Pantoprazole Sodium | Pantoprazole Sodium | 333 | 68 |
| Omeprazole | Omeprazole | 313 | 76 |
| Losartan Potassium | Losartan Potassium | 311 | 75 |
| Gabapentin | Gabapentin | 299 | 48 |
| Furosemide | Furosemide | 280 | 57 |
| Metformin Hcl | Metformin Hcl | 274 | 59 |
| Zolpidem Tartrate | Zolpidem Tartrate | 268 | 34 |
| Potassium Chloride | Potassium Chloride | 248 | 48 |
| Lisinopril | Lisinopril | 235 | 56 |
| Alprazolam | Alprazolam | 233 | 35 |
| Glimepiride | Glimepiride | 219 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 205 | 45 |
| Simvastatin | Simvastatin | 197 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 173 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 170 | 47 |
| Carvedilol | Carvedilol | 168 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 161 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 39 |
| Sertraline Hcl | Sertraline Hcl | 140 | 39 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 134 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 128 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 127 | 39 |
| Ozempic | Semaglutide | 127 | 20 |
| Eliquis | Apixaban | 120 | 24 |
| Montelukast Sodium | Montelukast Sodium | 108 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 106 | 26 |
| Atenolol | Atenolol | 105 | 27 |
| Allopurinol | Allopurinol | 102 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 95 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 94 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 92 | 13 |
| Meloxicam | Meloxicam | 91 | 17 |
| Temazepam | Temazepam | 91 | suppressed |
| Synthroid | Levothyroxine Sodium | 86 | 21 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 82 | 17 |
| Trazodone Hcl | Trazodone Hcl | 82 | 17 |
| Mounjaro | Tirzepatide | 81 | 13 |
| Jardiance | Empagliflozin | 78 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 70 | 16 |
| Metformin Hcl Er | Metformin Hcl | 67 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 66 | 50 |
| Farxiga | Dapagliflozin Propanediol | 66 | suppressed |
| Lorazepam | Lorazepam | 66 | 20 |
| Valsartan | Valsartan | 62 | 11 |
| Methylprednisolone | Methylprednisolone | 61 | 51 |
| Fluoxetine Hcl | Fluoxetine Hcl | 60 | 12 |
| Finasteride | Finasteride | 59 | 11 |
| Azithromycin | Azithromycin | 58 | 49 |
| Clonidine Hcl | Clonidine Hcl | 57 | suppressed |
| Ibuprofen | Ibuprofen | 56 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 55 | 11 |
| Glipizide | Glipizide | 52 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 51 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 51 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 51 | 12 |
| Tramadol Hcl | Tramadol Hcl | 51 | suppressed |
| Telmisartan | Telmisartan | 49 | 11 |
| Xarelto | Rivaroxaban | 49 | suppressed |
| Spironolactone | Spironolactone | 48 | 12 |
| Nystatin | Nystatin | 46 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 46 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 13 |
| Mirtazapine | Mirtazapine | 45 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 44 | suppressed |
| Celecoxib | Celecoxib | 43 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 43 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 40 | suppressed |
| Clonazepam | Clonazepam | 40 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 39 | suppressed |
| Famotidine | Famotidine | 39 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | suppressed |
| Trulicity | Dulaglutide | 38 | suppressed |
| Irbesartan | Irbesartan | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Bumetanide | Bumetanide | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Topiramate | Topiramate | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 33 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 33 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | suppressed |
| Ondansetron Odt | Ondansetron | 33 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 32 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 29 | suppressed |
| Invokana | Canagliflozin | 29 | suppressed |
| Jantoven | Warfarin Sodium | 29 | suppressed |
| Naproxen | Naproxen | 29 | suppressed |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 18 |
| Cefdinir | Cefdinir | 26 | 23 |
| Klor-Con M20 | Potassium Chloride | 26 | suppressed |
| Prednisone | Prednisone | 26 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 26 | suppressed |
| Tradjenta | Linagliptin | 26 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 25 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Rybelsus | Semaglutide | 21 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 18 |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 11 |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Armour Thyroid | Thyroid,pork | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Cefadroxil | Cefadroxil | 13 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 13 | suppressed |
| Levetiracetam Er | Levetiracetam | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Cartia Xt | Diltiazem Hcl | 12 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 12 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Clarithromycin | Clarithromycin | 11 | 11 |
| Colchicine | Colchicine | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Edluar | Zolpidem Tartrate | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $125.00 · 1 records | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error